Long-term clinical remission in IDH-mutated AML following IDH inhibitor therapy

Some AML patients achieve sustained remission with targeted IDH inhibitor therapy, transforming prognosis.

What the study was

Journal

Leuk Res

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.